Loading...
01/11 16:19
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call had mixed signals: strong Q4 performance with revenue and EBITDA growth, but full-year revenue declined. Guidance for Q1 2025 shows no growth. Regulatory challenges and competition pressures are significant risks. Positive cash flow and cash balance are offset by uncertainty in new product timelines and lack of revenue guidance. Overall, the sentiment is neutral due to balanced positive and negative factors.
Q4 2024 Revenue $47.7 million, increased 3% year-over-year, driven by growth from deal listings and display ad products, partially offset by lower spend on featured listings and the impact from products sunset in Q4 of last year.
Q4 2024 Adjusted EBITDA $11.9 million, representing a 25% margin, increased from $8.9 million (19% margin) in Q4 2023, due to better-than-expected revenues and continued lower spending trends.
Full Year 2024 Revenue $184.5 million, decreased from $188 million in the prior year, due to constraints in clients' marketing budgets, industry consolidation, and revenue loss from sunset products, partially offset by favorable pricing changes.
Full Year 2024 Average Monthly Paying Clients 5,077, decreased from 5,419 in the prior year, primarily due to client count related to sunset products and churn from industry challenges.
Full Year 2024 Net Income $12.2 million, compared to a net loss of $15.7 million in 2023, due to impairment charges and cost reductions.
Full Year 2024 Adjusted EBITDA $42.9 million, increased by $6 million over 2023, reflecting operational discipline during revenue headwinds.
Full Year 2024 Cash Generated $17.6 million, closing cash balance of $52 million, boosted by focus on accounts receivable and collections.
Full Year 2024 Free Cash Flow Higher-than-normal cash influx due to successful collection of past due accounts, not expected to be repeated.
Full Year 2024 GAAP OpEx Decreased 22% year-over-year, primarily driven by $24.4 million impairment charges taken last year.
New Product Initiatives: Expanding horizontally into the hemp shop and homegrown and seed markets, with anticipated launches in the second half of the year.
Market Expansion: Investing in developing and growing emerging markets, despite current challenges in states like New York and Florida.
Operational Efficiencies: Achieved a 27% reduction in GAAP OpEx compared to the prior year, driven by cost management and impairment charges from previous years.
Financial Position: Ended 2024 with a strong balance sheet, $52 million in cash, and a debt-free status.
Strategic Shifts: Prioritizing investments in technology and marketing to strengthen the Weedmaps platform and unlock future opportunities.
Regulatory Challenges: The cannabis industry faces significant regulatory burdens, including potential increases in excise taxes in California and ongoing regulatory uncertainty at both state and federal levels. This has led to consolidation in mature markets and challenges for operators.
Competitive Pressures: The company is contending with competition from both illicit markets and the hemp industry, which is flourishing due to a federal loophole. This competition is exacerbated by pricing pressures and budget constraints faced by clients.
Economic Factors: The overall health of the cannabis industry is under pressure due to economic factors, including client marketing budget constraints and the impact of consolidation among operators, which affects profitability and revenue.
Client Profitability: Ongoing industry pressures are impacting client profitability, leading to further consolidation and a decrease in average monthly revenue per paying client.
Market Dynamics: Emerging markets like New York and Florida are facing their own regulatory obstacles, which could alter the opportunity landscape for the company and its clients.
Investment Risks: While the company plans to invest in technology and marketing, these initiatives come with inherent risks due to the unpredictable nature of regulatory changes and market dynamics.
Investment in Technology and Marketing: In 2025, WM Technology plans to prioritize investments in technology and marketing to strengthen the Weedmaps platform and unlock future opportunities.
Expansion into New Markets: The company is executing key initiatives to capture emerging market trends, including expanding into the hemp shop and homegrown and seed markets, with anticipated launches in the second half of the year.
Operational Improvements: The operational improvements implemented over the last two years have positioned the company well to invest and build for future growth.
Focus on Client Acquisition and Retention: The company remains focused on adding new accounts and minimizing churn across all markets.
Q1 2025 Revenue Guidance: WM Technology expects Q1 revenues to be approximately $44 million, consistent with prior year results.
Q1 2025 Adjusted EBITDA Guidance: The company anticipates Q1 non-GAAP adjusted EBITDA to be approximately $7 million.
Full Year 2024 Revenue: Full year revenue for 2024 was $184.5 million, a decrease from $188 million in the prior year.
Full Year 2024 Adjusted EBITDA: Adjusted EBITDA for 2024 was $42.9 million, reflecting operational discipline during revenue headwinds.
Cash Balance: $52 million
Free Cash Flow: $17.6 million for the full year 2024
Share Count: Approximately 153 million shares as of December 31, 2024.
The earnings call highlights revenue decline, price compression, and regulatory challenges, which are significant concerns. While the company maintains profitability and cash reserves, the negative trends in core markets and client churn overshadow the positives. The lack of clear guidance and the focus on long-term prospects at the expense of near-term revenue add to the uncertainty, suggesting a negative market reaction.
The earnings call summary presents mixed signals. While there is modest revenue growth and positive cash generation, regulatory challenges and declining client spending pose risks. The Q2 guidance shows stability but lacks significant upside. Product development and client base growth are positive, but operational challenges and market pressures could offset gains. Without a strong catalyst or significant market cap details, the stock price is likely to remain stable in the near term.
The earnings call presented mixed signals. Positive aspects include revenue and EBITDA exceeding guidance, sequential growth, and a share buyback program. However, the EPS miss, regulatory risks, and competitive pressures introduce uncertainties. The Q&A highlighted ongoing challenges in the cannabis industry and lack of clarity on regulatory strategies. These factors balance out, leading to a neutral sentiment.
The earnings call highlights mixed signals: a slight revenue decline for the full year, but improved Q4 performance and profitability. Regulatory and competitive pressures pose risks, but management's optimism and new product launches offer potential upside. The Q&A reveals some uncertainty, particularly around supply chain issues and product timelines. Overall, the sentiment remains neutral, with no major catalysts for a significant stock move in either direction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
